SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001694665-23-000116
Filing Date
2023-07-12
Accepted
2023-07-12 16:03:45
Documents
2
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1689192216.html 3  
1 FORM 3 wk-form3_1689192216.xml 3 1649
2 EX-24 evelo-section16poaxjmoore7.htm EX-24 8466
  Complete submission text file 0001694665-23-000116.txt   11546
Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address 617-577-0300
Moore Jeffrey R. (Reporting) CIK: 0001469098 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38473 | Film No.: 231084247

Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations